https://www.avient.com/sites/default/files/resources/PolyOne%2520Proxy%2520Statement%25202016.pdf
Lin also serves as a director for two other public companies and one privately-held biomedical polymer company, which provides her with additional experience she utilizes while serving as a valued member of our Board.
Nominees for election to the Board are selected on the basis of the following criteria: ● Business or professional experience; ● Knowledge and skill in certain specialty areas such as accounting and finance, international markets, physical sciences and technology or the polymer or chemical industry; ● Personal characteristics such as ethical standards, integrity, judgment, leadership and the ability to devote sufficient time to our affairs; ● Substantial accomplishments with demonstrated leadership capabilities; ● Freedom from outside interests that conflict with our best interests; ● The diversity of backgrounds and experience each member will bring to the Board; and ● Our needs from time to time.
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Proxy%2520Statement.PDF
She has a deep understanding fof the specialty ctt hemicals industry, a strong operational foundation and wide-ranging international experience. .Ms Lin also serves as a director forff two other public companiess and one privately-held biomedical polymer company, whi hch provides her with additional experience she utilizes whi ele serving as a valued member of our Board.
Nominees for election to the Board are selected on the basis of the folff lowing criteria: ● Business or professional experience; ● Knowledge and skill in certain specialty areas such as accounting and finance, international markets, physical sciences and technology or the polymer or chemical industry; ● Personal characteristics such as ethical standards, integrity, judgment, leadership and the ability to devote sufficient time to our affaff irs; ● Substantial accomplishments with demonstrated leadership capabilities; ● Freedom froff m outside interests that conflict with our best interests; ● The diversity of backgrounds and experience each member will bring to the Board; and ● Our needs from time to time.
https://www.avient.com/sites/default/files/2022-03/Avient 2022 Proxy Statement.pdf
Lin also currently serves as a director for
two other public companies, one privately-held precision engineered drug
delivery company, and one privately-held biomedical polymer company, which
provides her with additional experience she utilizes while serving as a valued
member of our Board.